ISCA2 (Iron-sulfur cluster assembly 2 homolog, mitochondrial) variants and mutations
ISCA2 (also known as Iron-sulfur cluster assembly 2 homolog, mitochondrial) is a human protein-coding gene encoding an iron-sulfur cluster assembly 2 homolog, mitochondrial protein. Its annotated function is involved in the maturation of mitochondrial 4Fe-4S proteins functioning late in the iron-sulfur cluster assembly pathway. May be involved in the binding of an intermediate of Fe/S cluster assembly. It is annotated at the mitochondrion. This analysis covers 473 ISCA2 variants and mutations. Of these, 90% have computational variant effect predictions. Disease context includes multiple mitochondrial dysfunctions syndrome 4, optic atrophy, and neurodegenerative disease. Example ISCA2 variants include A2D, A2V, and A2T.
Variant analysis overview
- Gene: ISCA2
- Protein: Iron-sulfur cluster assembly 2 homolog, mitochondrial
- UniProt accession: Q86U28
- Organism: Homo sapiens
- Variants analyzed: 473
- Variant scope: all variants
- Completed: 2026-09-24
Variant and mutation evidence
- Variant composition: 196 unspecified-consequence records; 171 missense variants; 74 synonymous variants; 23 frameshift variants; 6 in-frame deletions; 4 splice-region variants; 4 stop-gained variants; 2 in-frame insertions; 1 substitution
- Prediction scores: 424 variants have prediction scores (90% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: multiple mitochondrial dysfunctions syndrome 4, optic atrophy, neurodegenerative disease, hereditary disease, mitochondrial disease, hereditary optic atrophy, Leber hereditary optic neuropathy, multiple mitochondrial dysfunctions syndrome 2, fatal multiple mitochondrial dysfunctions syndrome, Failure to thrive, Global developmental delay, Neurodegeneration.
Protein structure and variant hotspots
- Protein features: 3 binding sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ISCA2 variants
Examples include A2D, A2V, A2T, A2S, A2A, A3S, A3T, A3V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2D (p.Ala2Asp), ExAC rs777458795, TOPMed rs777458795, gnomAD rs777458795, REVEL 0.18, CADD 26.00
- A2V (p.Ala2Val), ExAC rs777458795, TOPMed rs777458795, gnomAD rs777458795, REVEL 0.10, CADD 24.00
- A2T (p.Ala2Thr), gnomAD 14-74493778-G-A, REVEL 0.06, CADD 24.60
- A2S (p.Ala2Ser), gnomAD 14-74493778-G-T, REVEL 0.07, CADD 23.90
- A2A (p.Ala2Ala), gnomAD 14-74493780-T-C, CADD 14.10
- A3S (p.Ala3Ser), gnomAD 14-74493781-G-T, REVEL 0.03, CADD 19.60
- A3T (p.Ala3Thr), gnomAD 14-74493781-G-A, REVEL 0.04, CADD 23.30
- A3V (p.Ala3Val), gnomAD 14-74493782-C-T, REVEL 0.02, CADD 22.30
- A3D (p.Ala3Asp), gnomAD 14-74493782-C-A, REVEL 0.05, CADD 23.50
- A3A (p.Ala3Ala), gnomAD 14-74493783-C-A, CADD 9.75
- A4D (p.Ala4Asp), gnomAD rs1214092510, REVEL 0.03, CADD 15.10
- A4P (p.Ala4Pro), TOPMed rs2086809318
- A4V (p.Ala4Val), gnomAD rs1214092510, REVEL 0.08, CADD 7.17, Uncertain significance, Inborn genetic diseases
- A4T (p.Ala4Thr), gnomAD 14-74493784-G-A, REVEL 0.07, CADD 11.10
- A4S (p.Ala4Ser), gnomAD 14-74493784-G-T, REVEL 0.08, CADD 5.51
- A4A (p.Ala4Ala), rs746679489, gnomAD 14-74493786-C-T, CADD 9.37
- W5* (p.Trp5Ter), cosmic curated COSV10803, TOPMed rs1339989244, gnomAD rs1339989244, CADD 36.00
- W5R (p.Trp5Arg), TOPMed rs1215329371, REVEL 0.14, CADD 0.73
- W5L (p.Trp5Leu), gnomAD 14-74493786-C-CT, CADD 17.30
- W5G (p.Trp5Gly), gnomAD 14-74493787-T-G, REVEL 0.09, CADD 4.80
- W5S (p.Trp5Ser), gnomAD 14-74493788-G-C, REVEL 0.09, CADD 19.40
- W5C (p.Trp5Cys), gnomAD 14-74493789-G-T, REVEL 0.03, CADD 14.40
- G6A (p.Gly6Ala), NCI-TCGA Cosmic COSV9946, cosmic curated COSV99467, Variant assessed as somatic; moderate impact.
- G6E (p.Gly6Glu), gnomAD rs2086809725, REVEL 0.02, CADD 14.70
- G6R (p.Gly6Arg), 1000Genomes rs1207122929, TOPMed rs1207122929, gnomAD rs1207122929, REVEL 0.04, CADD 16.40, Uncertain significance, Inborn genetic diseases
- G6W (p.Gly6Trp), gnomAD 14-74493790-G-T, REVEL 0.06, CADD 21.90
- G6V (p.Gly6Val), gnomAD 14-74493791-G-T, REVEL 0.07, CADD 15.10
- G6G (p.Gly6Gly), gnomAD 14-74493792-G-T, CADD 7.32
- S7* (p.Ser7Ter), ExAC rs780853372, TOPMed rs780853372, gnomAD rs780853372, CADD 33.00
- S7W (p.Ser7Trp), ExAC rs780853372, TOPMed rs780853372, gnomAD rs780853372, REVEL 0.02, CADD 14.60
- S7R (p.Ser7Arg), rs950263114, gnomAD 14-74493787-TG-T, CADD 23.60
- S7P (p.Ser7Pro), gnomAD 14-74493793-T-C, REVEL 0.24, CADD 8.29
- S7T (p.Ser7Thr), gnomAD 14-74493793-T-A, REVEL 0.01, CADD 2.15
- S7L (p.Ser7Leu), gnomAD 14-74493794-C-T, REVEL 0.02, CADD 10.00
- S7S (p.Ser7Ser), gnomAD 14-74493795-G-T, CADD 7.77
- S8F (p.Ser8Phe), gnomAD rs1248063555, REVEL 0.03, CADD 7.74
- S8T (p.Ser8Thr), gnomAD 14-74493796-T-A, REVEL 0.10, CADD 10.40
- S8P (p.Ser8Pro), gnomAD 14-74493796-T-C, REVEL 0.09, CADD 15.10
- S8Y (p.Ser8Tyr), gnomAD 14-74493797-C-A, REVEL 0.03, CADD 4.19
- S8S (p.Ser8Ser), gnomAD 14-74493798-C-A, CADD 4.88
- L9Q (p.Leu9Gln), TOPMed rs1044687761, gnomAD rs1044687761, REVEL 0.06, CADD 15.00, Uncertain significance, Inborn genetic diseases; not provided
- L9V (p.Leu9Val), TOPMed rs1478129518, gnomAD rs1478129518, REVEL 0.02, CADD 0.47
- L9I (p.Leu9Ile), gnomAD 14-74493799-C-A, REVEL 0.03, CADD 1.52
- L9L (p.Leu9Leu), rs1478129518, gnomAD 14-74493799-C-T, CADD 5.53
- L9P (p.Leu9Pro), gnomAD 14-74493800-T-C, REVEL 0.08, CADD 15.80
- T10M (p.Thr10Met), rs919184603, ClinGen CA263573433, ClinVar RCV001976321, gnomAD rs919184603, REVEL 0.07, CADD 14.20, Uncertain significance, not provided
- T10S (p.Thr10Ser), gnomAD rs1387724988, REVEL 0.05, CADD 1.96
- T10R (p.Thr10Arg), gnomAD 14-74493800-TA-T, CADD 18.10
- T10A (p.Thr10Ala), gnomAD 14-74493802-A-G, REVEL 0.09, CADD 5.38
- T10K (p.Thr10Lys), gnomAD 14-74493803-C-A, REVEL 0.02, CADD 9.06
- T10T (p.Thr10Thr), gnomAD 14-74493804-G-T, CADD 6.28
- A11V (p.Ala11Val), ExAC rs745738187, gnomAD rs745738187, REVEL 0.04, CADD 10.30
- A11S (p.Ala11Ser), gnomAD 14-74493805-G-T, REVEL 0.09, CADD 14.70
- A11T (p.Ala11Thr), gnomAD 14-74493805-G-A, REVEL 0.15, CADD 15.70
- A11D (p.Ala11Asp), gnomAD 14-74493806-C-A, REVEL 0.14, CADD 16.10
- A11A (p.Ala11Ala), rs760280171, gnomAD 14-74493807-C-G, CADD 5.29
- A12G (p.Ala12Gly), TOPMed rs1005573226, gnomAD rs1005573226
- A12T (p.Ala12Thr), Ensembl rs868097207, REVEL 0.02, CADD 8.24
- A12V (p.Ala12Val), TOPMed rs1005573226, gnomAD rs1005573226, REVEL 0.08, CADD 8.31
- A12S (p.Ala12Ser), gnomAD 14-74493808-G-T, REVEL 0.01, CADD 4.05
- A12E (p.Ala12Glu), gnomAD 14-74493809-C-A, REVEL 0.09, CADD 7.37
- A12A (p.Ala12Ala), rs2086810569, gnomAD 14-74493810-G-A, CADD 7.73
- T13del (p.Thr13del), rs761094131, gnomAD 14-74493808-GCGA-, CADD 10.60
- T13S (p.Thr13Ser), gnomAD 14-74493811-A-T, REVEL 0.03, CADD 7.96
- T13A (p.Thr13Ala), gnomAD 14-74493811-A-G, REVEL 0.02, CADD 6.54
- T13K (p.Thr13Lys), gnomAD 14-74493812-C-A, REVEL 0.07, CADD 12.20
- T13M (p.Thr13Met), gnomAD 14-74493812-C-T, REVEL 0.05, CADD 17.40
- T13R (p.Thr13Arg), gnomAD 14-74493812-C-G, REVEL 0.07, CADD 12.50
- T13T (p.Thr13Thr), rs2086810621, gnomAD 14-74493813-G-T, CADD 4.22
- Q14* (p.Gln14Ter), gnomAD rs1350706747
- Q14L (p.Gln14Leu), TOPMed rs1443774530, gnomAD rs1443774530, REVEL 0.05, CADD 11.00, Likely benign, Inborn genetic diseases
- Q14R (p.Gln14Arg), TOPMed rs1443774530, gnomAD rs1443774530, REVEL 0.04, CADD 8.82
- Q14K (p.Gln14Lys), gnomAD 14-74493814-C-A, REVEL 0.13, CADD 2.18
- Q14Q (p.Gln14Gln), gnomAD 14-74493816-G-A, CADD 4.73
- Q14H (p.Gln14His), gnomAD 14-74493816-G-C, REVEL 0.02, CADD 4.89
- R15R (p.Arg15Arg), gnomAD 14-74493817-A-C, CADD 9.41
- R15G (p.Arg15Gly), gnomAD 14-74493817-A-G, REVEL 0.03, CADD 19.50
- R15I (p.Arg15Ile), gnomAD 14-74493818-G-T, REVEL 0.11, CADD 17.70
- R15S (p.Arg15Ser), gnomAD 14-74493819-A-T, REVEL 0.08, CADD 13.40
- A16T (p.Ala16Thr), NCI-TCGA Cosmic COSV5314, cosmic curated COSV53143, TOPMed rs2086810771, gnomAD rs2086810771, REVEL 0.09, CADD 14.00, Variant assessed as somatic; moderate impact.
- A16V (p.Ala16Val), TOPMed rs868238817, gnomAD rs868238817, REVEL 0.03, CADD 7.56
- A16R (p.Ala16Arg), gnomAD 14-74493819-AG-A, CADD 22.10
- A16S (p.Ala16Ser), gnomAD 14-74493820-G-T, REVEL 0.07, CADD 12.30
- A16E (p.Ala16Glu), gnomAD 14-74493821-C-A, REVEL 0.07, CADD 9.64
- A16A (p.Ala16Ala), rs949383555, gnomAD 14-74493822-G-A, CADD 3.85
- V17I (p.Val17Ile), gnomAD 14-74493823-G-A, REVEL 0.07, CADD 11.20
- V17A (p.Val17Ala), gnomAD 14-74493824-T-C, REVEL 0.02, CADD 15.90
- V17V (p.Val17Val), rs2139677605, gnomAD 14-74493825-C-A, CADD 13.10
- T18N (p.Thr18Asn), Ensembl rs2139677612, REVEL 0.04, CADD 9.68
- T18P (p.Thr18Pro), Ensembl rs2086810937
- T18A (p.Thr18Ala), gnomAD 14-74493826-A-G, REVEL 0.01, CADD 9.48
- T18I (p.Thr18Ile), gnomAD 14-74493827-C-T, REVEL 0.09, CADD 11.30
- T18S (p.Thr18Ser), gnomAD 14-74493827-C-G, REVEL 0.05, CADD 15.30
- T18T (p.Thr18Thr), gnomAD 14-74493828-T-C, CADD 3.41
- P19A (p.Pro19Ala), ExAC rs769838954, TOPMed rs769838954, gnomAD rs769838954, REVEL 0.03, CADD 9.72, Uncertain significance
- P19L (p.Pro19Leu), gnomAD rs1367435389, REVEL 0.02, CADD 9.46
- P19S (p.Pro19Ser), rs769838954, ClinGen CA7268248, cosmic curated COSV10456, ClinVar RCV004403390, REVEL 0.04, CADD 11.70, Uncertain significance, Inborn genetic diseases
- P19T (p.Pro19Thr), gnomAD 14-74493829-C-A, REVEL 0.02, CADD 11.00
- P19H (p.Pro19His), gnomAD 14-74493830-C-A, REVEL 0.03, CADD 8.75
- P19P (p.Pro19Pro), gnomAD 14-74493831-C-A, CADD 4.88
- W20* (p.Trp20Ter), ExAC rs749090744, gnomAD rs749090744, CADD 36.00
- W20R (p.Trp20Arg), gnomAD 14-74493832-T-A, REVEL 0.10, CADD 15.60
- W20S (p.Trp20Ser), gnomAD 14-74493833-G-C, REVEL 0.17, CADD 19.50
- W20L (p.Trp20Leu), gnomAD 14-74493833-G-T, REVEL 0.08, CADD 18.10
- W20C (p.Trp20Cys), gnomAD 14-74493834-G-T, REVEL 0.10, CADD 22.60
- P21A (p.Pro21Ala), TOPMed rs2086811150, REVEL 0.06, CADD 10.90
- P21L (p.Pro21Leu), rs372853525, ClinGen CA7268251, ClinVar RCV001981542, ClinVar RCV005854122, REVEL 0.06, CADD 5.87, Uncertain significance, Inborn genetic diseases; not provided
- P21T (p.Pro21Thr), gnomAD 14-74493835-C-A, REVEL 0.02, CADD 10.20
- P21S (p.Pro21Ser), gnomAD 14-74493835-C-T, REVEL 0.02, CADD 12.60
- P21Q (p.Pro21Gln), gnomAD 14-74493836-C-A, REVEL 0.05, CADD 6.32
- P21R (p.Pro21Arg), gnomAD 14-74493836-C-G, REVEL 0.06, CADD 5.88
- P21P (p.Pro21Pro), rs1378121431, gnomAD 14-74493837-G-C, CADD 6.61
- R22G (p.Arg22Gly), cosmic curated COSV53143, gnomAD rs1226430569, REVEL 0.14, CADD 16.50
- R22S (p.Arg22Ser), 1000Genomes rs571679292, ExAC rs571679292, TOPMed rs571679292, gnomAD rs571679292, REVEL 0.20, CADD 19.70
- R22M (p.Arg22Met), gnomAD 14-74493839-G-T, REVEL 0.14, CADD 7.32
- R22K (p.Arg22Lys), gnomAD 14-74493839-G-A, REVEL 0.15, CADD 1.81
- R22R (p.Arg22Arg), rs571679292, gnomAD 14-74493840-G-A, CADD 14.90
- G23D (p.Gly23Asp), gnomAD rs1451835980, REVEL 0.08, CADD 16.10
- G23R (p.Gly23Arg), rs2506118027, ClinGen CA390377540, ClinVar RCV002833019, Uncertain significance, not provided
- G23A (p.Gly23Ala), gnomAD 14-74493838-AG-A, CADD 14.60
- G23S (p.Gly23Ser), gnomAD 14-74493841-G-A, REVEL 0.09, CADD 12.40
- G23V (p.Gly23Val), gnomAD 14-74493842-G-T, REVEL 0.08, CADD 17.60
- G23G (p.Gly23Gly), rs2086811374, gnomAD 14-74493843-C-T, CADD 27.40
- R24T (p.Arg24Thr), gnomAD rs1245744358, REVEL 0.13, CADD 34.00
- R24W (p.Arg24Trp), gnomAD rs1207642936, REVEL 0.32, CADD 35.00
- R24R (p.Arg24Arg), gnomAD 14-74493844-A-C, CADD 23.30
- R24G (p.Arg24Gly), gnomAD 14-74493844-A-G, REVEL 0.21, CADD 26.70
- R24K (p.Arg24Lys), gnomAD 14-74493845-G-A, REVEL 0.09, CADD 33.00
- R24M (p.Arg24Met), gnomAD 14-74493845-G-T, REVEL 0.50, CADD 35.00
- R24S (p.Arg24Ser), gnomAD 14-74494050-G-C, REVEL 0.50, CADD 23.60
- L25V (p.Leu25Val), gnomAD 14-74494051-C-G, REVEL 0.05, CADD 15.70
- L25I (p.Leu25Ile), gnomAD 14-74494051-C-A, REVEL 0.04, CADD 15.90
- L25F (p.Leu25Phe), gnomAD 14-74494051-C-T, REVEL 0.07, CADD 22.10
- L25L (p.Leu25Leu), gnomAD 14-74494053-C-A, CADD 9.51
- L26I (p.Leu26Ile), gnomAD 14-74494054-C-A, REVEL 0.08, CADD 16.10
- L26L (p.Leu26Leu), rs2086814503, gnomAD 14-74494056-C-T, CADD 8.55
- T27A (p.Thr27Ala), Ensembl rs2139677908, REVEL 0.04, CADD 13.40
- T27M (p.Thr27Met), gnomAD 14-74494058-C-T, REVEL 0.05, CADD 17.80
- T27K (p.Thr27Lys), gnomAD 14-74494058-C-A, REVEL 0.06, CADD 15.10
- T27T (p.Thr27Thr), gnomAD 14-74494059-G-A, CADD 9.43
- A28G (p.Ala28Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A28V (p.Ala28Val), rs371830968, ClinGen CA7268264, ClinVar RCV002127125, ClinVar RCV003903382, REVEL 0.02, CADD 18.70, Conflicting interpretations, not provided
- A28S (p.Ala28Ser), gnomAD 14-74494060-G-T, REVEL 0.02, CADD 14.90
- A28D (p.Ala28Asp), gnomAD 14-74494061-C-A, REVEL 0.08, CADD 18.90
- A28A (p.Ala28Ala), gnomAD 14-74494062-C-T, CADD 10.60
- S29F (p.Ser29Phe), cosmic curated COSV10499, Ensembl rs2086814618, REVEL 0.03, CADD 13.60, Uncertain significance, not provided
- S29T (p.Ser29Thr), gnomAD 14-74494063-T-A, REVEL 0.03, CADD 15.90
- S29C (p.Ser29Cys), gnomAD 14-74494064-C-G, REVEL 0.05, CADD 13.90
- S29S (p.Ser29Ser), gnomAD 14-74494065-C-A, CADD 7.71
- L30P (p.Leu30Pro), TOPMed rs2086814732
- L30Q (p.Leu30Gln), TOPMed rs2086814732
- L30W (p.Leu30Trp), gnomAD 14-74494063-TC-T, CADD 21.30
- L30L (p.Leu30Leu), rs955792633, gnomAD 14-74494066-C-T, CADD 5.79
- G31C (p.Gly31Cys), NCI-TCGA Cosmic COSV5314, cosmic curated COSV53143, Variant assessed as somatic; moderate impact.
- G31D (p.Gly31Asp), gnomAD 14-74494067-TG-T, CADD 22.70
- G31R (p.Gly31Arg), gnomAD 14-74494069-G-C, REVEL 0.06, CADD 6.49
- G31* (p.Gly31Ter), gnomAD 14-74494069-G-T, CADD 33.00
- G31V (p.Gly31Val), gnomAD 14-74494069-G-GT, CADD 23.30
- G31E (p.Gly31Glu), gnomAD 14-74494070-G-A, REVEL 0.11, CADD 8.43
- G31G (p.Gly31Gly), gnomAD 14-74494071-A-T, CADD 9.37
- P32T (p.Pro32Thr), gnomAD 14-74494072-C-A, REVEL 0.13, CADD 10.40
- P32H (p.Pro32His), gnomAD 14-74494073-C-A, REVEL 0.02, CADD 9.50
- P32L (p.Pro32Leu), gnomAD 14-74494073-C-T, REVEL 0.02, CADD 8.64
- P32P (p.Pro32Pro), gnomAD 14-74494074-C-A, CADD 5.49
- Q33R (p.Gln33Arg), gnomAD 14-74494071-AC-A, CADD 22.50
- Q33K (p.Gln33Lys), gnomAD 14-74494075-C-A, REVEL 0.06, CADD 3.67
- Q33E (p.Gln33Glu), gnomAD 14-74494075-C-G, REVEL 0.03, CADD 1.73
- Q33L (p.Gln33Leu), gnomAD 14-74494076-A-T, REVEL 0.04, CADD 1.09
- Q33H (p.Gln33His), gnomAD 14-74494077-G-T, REVEL 0.04, CADD 19.90
- Q33Q (p.Gln33Gln), gnomAD 14-74494077-G-A, CADD 11.10
- A34T (p.Ala34Thr), gnomAD 14-74494078-G-A, REVEL 0.02, CADD 16.40
- A34S (p.Ala34Ser), gnomAD 14-74494078-G-T, REVEL 0.02, CADD 14.40
- A34E (p.Ala34Glu), gnomAD 14-74494079-C-A, REVEL 0.10, CADD 16.90
- A34V (p.Ala34Val), gnomAD 14-74494079-C-T, REVEL 0.13, CADD 18.20
- A34A (p.Ala34Ala), gnomAD 14-74494080-G-A, CADD 11.80
- R35L (p.Arg35Leu), cosmic curated COSV53142, gnomAD rs1336080975, REVEL 0.04, CADD 16.70, Uncertain significance, not provided
- R35S (p.Arg35Ser), gnomAD 14-74494081-C-A, REVEL 0.09, CADD 20.80
- R35C (p.Arg35Cys), gnomAD 14-74494081-C-T, REVEL 0.09, CADD 24.10
- R35H (p.Arg35His), gnomAD 14-74494082-G-A, REVEL 0.04, CADD 17.40
- R35R (p.Arg35Arg), gnomAD 14-74494083-T-C, CADD 15.30
Public ISCA2 analysis runs
- ISCA2 analysis run — ISCA2 (473 variants) — completed 2026-09-24